Green synthesis of Ag and Cu-doped Bismuth oxide nanoparticles: Revealing synergistic antimicrobial and selective cytotoxic potentials for biomedical advancements.

Antibacterial activity Bismuth oxide nanoparticles Cytotoxicity Green synthesis Nanotechnology

Journal

Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS)
ISSN: 1878-3252
Titre abrégé: J Trace Elem Med Biol
Pays: Germany
ID NLM: 9508274

Informations de publication

Date de publication:
Jan 2024
Historique:
received: 07 08 2023
revised: 15 10 2023
accepted: 19 10 2023
pubmed: 6 11 2023
medline: 6 11 2023
entrez: 3 11 2023
Statut: ppublish

Résumé

Nanotechnology has emerged as a transformative realm of exploration across diverse scientific domains. A particular focus lies on metal oxide nanoparticles, which boast distinctive physicochemical attributes on the nanoscale. Of note, green synthesis has emerged as a promising avenue, leveraging plant extracts as both reduction and capping agents. This approach offers environmentally friendly and cost-effective avenues for generating monodispersed nanoparticles with precise morphologies. In this investigation, we embarked on the synthesis of Bismuth oxide nanoparticles, both in their pure form and doped with silver (Ag) and copper (Cu). This synthesis harnessed the potential of Biebersteinia multifida extract as a versatile reducing agent. To comprehensively characterize the synthesized nanoparticles, a suite of analytical techniques was employed, including energy-dispersive X-ray spectroscopy, field-emission scanning electron microscopy (FESEM), X-ray diffraction (XRD), Fourier-transform infrared spectroscopy (FT-IR), UV-Vis spectroscopy, and Raman spectroscopy. The synthesized nanoparticles underwent a rigorous assessment. Their antibacterial attributes were probed, revealing a pronounced enhancement in antibiofilm activity against Pseudomonas aeruginosa and Staphylococcus aureus bacteria upon metal nanoparticle doping. Furthermore, their potential for combating cancer was scrutinized, with the nanoparticles exhibiting selective cytotoxicity towards cancer cells, U87, compared to normal 3T3 cells. Notably, among the doped nanoparticles, Cu-doped variants demonstrated the highest potency, further underscoring their promising potential. In conclusion, the present study underscores the efficacy of green synthesized Bismuth oxide nanoparticles, particularly those doped with Ag and Cu, in augmenting antibacterial efficacy, bolstering biofilm inhibition, and manifesting selective cytotoxicity against cancer cells. These findings portend a promising trajectory for these nanoparticles in the spheres of biomedicine and therapeutics. As we look ahead, a deeper elucidation of their mechanistic underpinnings and in vivo investigations are essential to fully unlock their potential for forthcoming biomedical applications.

Sections du résumé

BACKGROUND BACKGROUND
Nanotechnology has emerged as a transformative realm of exploration across diverse scientific domains. A particular focus lies on metal oxide nanoparticles, which boast distinctive physicochemical attributes on the nanoscale. Of note, green synthesis has emerged as a promising avenue, leveraging plant extracts as both reduction and capping agents. This approach offers environmentally friendly and cost-effective avenues for generating monodispersed nanoparticles with precise morphologies.
METHODS METHODS
In this investigation, we embarked on the synthesis of Bismuth oxide nanoparticles, both in their pure form and doped with silver (Ag) and copper (Cu). This synthesis harnessed the potential of Biebersteinia multifida extract as a versatile reducing agent. To comprehensively characterize the synthesized nanoparticles, a suite of analytical techniques was employed, including energy-dispersive X-ray spectroscopy, field-emission scanning electron microscopy (FESEM), X-ray diffraction (XRD), Fourier-transform infrared spectroscopy (FT-IR), UV-Vis spectroscopy, and Raman spectroscopy.
RESULTS RESULTS
The synthesized nanoparticles underwent a rigorous assessment. Their antibacterial attributes were probed, revealing a pronounced enhancement in antibiofilm activity against Pseudomonas aeruginosa and Staphylococcus aureus bacteria upon metal nanoparticle doping. Furthermore, their potential for combating cancer was scrutinized, with the nanoparticles exhibiting selective cytotoxicity towards cancer cells, U87, compared to normal 3T3 cells. Notably, among the doped nanoparticles, Cu-doped variants demonstrated the highest potency, further underscoring their promising potential.
CONCLUSION CONCLUSIONS
In conclusion, the present study underscores the efficacy of green synthesized Bismuth oxide nanoparticles, particularly those doped with Ag and Cu, in augmenting antibacterial efficacy, bolstering biofilm inhibition, and manifesting selective cytotoxicity against cancer cells. These findings portend a promising trajectory for these nanoparticles in the spheres of biomedicine and therapeutics. As we look ahead, a deeper elucidation of their mechanistic underpinnings and in vivo investigations are essential to fully unlock their potential for forthcoming biomedical applications.

Identifiants

pubmed: 37922658
pii: S0946-672X(23)00201-8
doi: 10.1016/j.jtemb.2023.127325
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

127325

Informations de copyright

Copyright © 2023 Elsevier GmbH. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Mina Sarani (M)

Zabol Medicinal Plants Research Center, Zabol University of Medical Sciences, Zabol, Iran.

Maryam Roostaee (M)

Department of Chemistry, Shahid Bahonar University of Kerman, Kerman, Iran.

Mahboubeh Adeli-Sardou (M)

Herbal and Traditional Medicines Research Center, Kerman University of Medical Sciences, Kerman, Iran; Department of Biotechnology, Institute of Science and High Technology and Environmental Sciences, Graduate University of Advanced Technology, Kerman, Iran.

Davood Kalantar-Neyestanaki (D)

Medical Mycology and Bacteriology Research Center, Kerman University of Medical Sciences, Kerman, Iran; Department of Medical Microbiology (Bacteriology and virology), Afzalipour Faculty of Medicine, Kerman University of Medical Sciences, Kerman 7616913555, Iran.

Seyed Amin Ayatollahi Mousavi (SAA)

Medical Mycology and Bacteriology Research Center, Kerman University of Medical Sciences, Kerman, Iran; Department of Medical Mycology and Parasitology, Faculty of Medicine, Kerman University of Medical Sciences, Kerman, Iran.

Azam Amanizadeh (A)

Department of Medical Mycology and Parasitology, Faculty of Medicine, Kerman University of Medical Sciences, Kerman, Iran.

Mahmood Barani (M)

Medical Mycology and Bacteriology Research Center, Kerman University of Medical Sciences, Kerman, Iran. Electronic address: mahmoodbarani7@gmail.com.

Alireza Amirbeigi (A)

Department of General Surgery, School of Medicine, Kerman University of Medical Sciences, Kerman, Iran. Electronic address: ali_amirbeigi@yahoo.com.

Classifications MeSH